These guidelines provide detailed instructions for authors preparing and submitting manuscripts to the Journal of Hematology and Clinical Research (JHCR). Following these instructions helps ensure efficient peer review, clear presentation of research, and compliance with ethical and formatting standards set by COPE, DOAJ, ICMJE, and WAME.

Article Types Accepted

  • Original Research Articles
  • Review and Mini Review Articles
  • Case Reports and Clinical Trials
  • Short Communications
  • Letters to the Editor
  • Editorials, Opinions, and Commentaries

Manuscript Structure

All manuscripts should follow the IMRaD format: Introduction, Methods, Results, and Discussion. Supplementary sections should include acknowledgments, conflicts of interest, funding statements, author contributions, and references.

Section Content Details
Title Page Full title, author names and affiliations, corresponding author contact, short running title, and ORCID IDs.
Abstract Structured summary (250 words maximum) with background, methods, results, and conclusions. Include 4–6 keywords.
Main Text Divided into Introduction, Methods, Results, and Discussion sections, written in clear and concise English.
References Follow the NLM (Vancouver) citation style. List all authors up to six; if more, list the first six followed by “et al.”

Formatting and Style

  • File type: Microsoft Word (.docx) or Rich Text Format (.rtf)
  • Font: Times New Roman, size 12, double-spaced
  • Margins: 1 inch on all sides
  • Pagination: Number all pages consecutively
  • Headings: Use consistent hierarchical structure (H1, H2, H3)
  • Tables and Figures: Each table/figure must be numbered sequentially and cited in text

Figures, Tables, and Supplementary Files

High-resolution figures (minimum 300 dpi) should be submitted in .jpg, .png, or .tiff formats. Tables must be editable, not embedded images. Supplementary data such as videos or datasets should include DOIs or repository links.

Ethical Compliance and Permissions

  • Human and Animal Research: State approval by Institutional Review Board (IRB) or Ethics Committee.
  • Informed Consent: Required for studies involving identifiable human data or clinical images.
  • Conflict of Interest: Disclose any financial or non-financial interests.
  • Plagiarism Screening: All submissions are checked via iThenticate.

Authorship and Contribution

Authorship is based on the ICMJE criteria. Each author must have contributed substantially to the conception, design, data acquisition, or analysis, and must approve the final version. Use the CRediT taxonomy to define specific roles (Conceptualization, Data Curation, Writing, etc.).

Manuscript Submission

Authors can submit manuscripts directly via the online submission system or email to the editorial office. The manuscript must include all essential sections, separate title page, and blinded version for double-blind peer review.

Submission Email: [email protected]

Peer Review Process

All manuscripts undergo double-blind peer review. Reviewers remain anonymous to authors, and vice versa. The editorial team ensures fair and timely evaluation of submissions, guided by the Peer Review Policy.

Data Availability and Transparency

Authors are encouraged to deposit data, software, and supplementary materials in recognized open repositories (e.g., Zenodo, Dryad, Figshare). Each dataset should be referenced in the manuscript with a DOI.

Reference Format (NLM/Vancouver Style)

JHCR uses the NLM citation style. Examples:

  • Journal article: Smith J, Brown K. Advances in clinical hematology. J Hematol Clin Res. 2022;8(2):45–56.
  • Book: White A. Principles of Hematology. New York: Academic Press; 2021.
  • Book chapter: Taylor R. Hemostasis. In: Miller P, editor. Hematology Essentials. Springer; 2020. p. 34–48.

Compliance with Journal Policies

Authors must review the following related policies prior to submission:

FAQs

What is the preferred length of an article?

Original research articles should not exceed 5,000 words (excluding references); short communications up to 1,500 words; reviews up to 8,000 words.

Can I submit a preprint?

Yes. Preprints are accepted provided the version submitted to JHCR is original and not under review elsewhere.

Are supplementary data accepted?

Yes. Multimedia, datasets, and figures are welcome if referenced in the manuscript.

Do I need to anonymize my file for peer review?

Yes. Remove author names and affiliations from the main document for double-blind review.

Is there a submission deadline?

Submissions are accepted year-round for continuous publication.

Contact

Editorial Office – Journal of Hematology and Clinical Research (JHCR)
Heighten Science Publications Inc.
Website: https://www.hematologyresjournal.com/
Email: [email protected]

Sources from the legacy site: Author Guidelines (IMRaD format, NLM references, submission instructions). Title and abstract structure (250 words, 4–6 keywords). Reference examples (NLM/Vancouver). Figure and table specifications. Ethics and plagiarism check (iThenticate). Authorship and CRediT criteria. Submission methods and contact emails. Peer review process (double-blind). Data sharing and preprint policy.

Copyright © 2016–2025 Journal of Hematology and Clinical Research (JHCR) – Heighten Science Publications Inc. Licensed under CC BY 4.0.